Children with acute lymphoblastic leukemia (ALL) and high minimal residual disease (MRD) levels after initial chemotherapy have a poor clinical outcome. In this prospective, single arm, Phase 2 trial, ...

To further improve the outcome for children with acute lymphoblastic leukemia (ALL) in The Netherlands, the Dutch Childhood Leukemia Study Group (DCLSG) has co-operated with the ...

Data on survival outcomes in patients with acute lymphoblastic leukemia (ALL) originating from Nepal are limited. We aim to present the real-world data on treatment outcomes of patients with de novo ...